Evidence map›Paper›PMID 41671251›Full record

ArticlePLOS global public health2026

Timeliness of vaccine administration among children in urban informal settlements in Nairobi, Kenya.

Maurine Ng'oda, Jonathan Izudi, Collins Omenda, Anne Njeri, Nelson Mbaya, Abdhalah Ziraba

Abstract read
In one paragraph

Article in PLOS global public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maurine Ng'odaEmerging and Re-emerging Infectious Diseases Unit, African Population and Health Research Center, Nairobi, Kenya.ORCID https://orcid.org/0000-0003-2619-562X
Jonathan IzudiDepartment of Community Health, Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda.ORCID https://orcid.org/0000-0001-9065-0389
Collins OmendaEmerging and Re-emerging Infectious Diseases Unit, African Population and Health Research Center, Nairobi, Kenya.ORCID https://orcid.org/0009-0004-7321-9086
Anne NjeriEmerging and Re-emerging Infectious Diseases Unit, African Population and Health Research Center, Nairobi, Kenya.
Nelson MbayaEmerging and Re-emerging Infectious Diseases Unit, African Population and Health Research Center, Nairobi, Kenya.
Abdhalah ZirabaEmerging and Re-emerging Infectious Diseases Unit, African Population and Health Research Center, Nairobi, Kenya.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Timeliness of vaccination among children in urban informal settlements is understudied in sub-Saharan Africa. We determined the proportion of children below 5 years who received vaccines on time and the associated factors in two large urban informal settlements in Nairobi, Kenya. We conducted an analytic cross-sectional study in Viwandani and Korogocho, randomly selected households with a child below 5 years, and administered questionnaires to mothers/caregivers. Timely vaccination was defined according to the Kenya Expanded Programme on Immunization schedule. Vaccination was considered timely if administered within 28 days of birth for Bacille Calmette-Guérin (BCG), between 14 and 18 weeks for Diphtheria-Tetanus-Pertussis-Haemophilus influenzae type b-Hepatitis B dose 3 (DTP-Hib-HepB-3), and between 9 and 10 months for Measles-Containing Vaccine dose 1 (MCV1). Multivariable modified Poisson regression identified the factors associated with timely vaccination. Of 412 children, 216 (52%) with verifiable immunization booklets were analyzed for timeliness. Timely vaccination rates were 90.4% for BCG (189/209), 90.2% for DTP-HIB-Hep-3 (184/204), and 84.2% for MCV1 (160/190). Factors associated with timely vaccination included caregiver uncertainty about access to health services, which reduced the likelihood of timely BCG (adjusted prevalence risk ratio [aPR] 0.87, 95% confidence interval [CI] 0.78-0.96), DTP-Hib-HepB-3 (aPR 0.88, 95% CI 0.79-0.98), and MCV1 (aPR 0.81, 95% CI 0.70-0.94). Compared with Korogocho, children in Viwandani were more likely to receive timely MCV1 (aPR 1.18, 95% CI 1.03-1.35), whereas children of Christian caregivers were less likely than those of non-religious caregivers (aPR 0.83, 95% CI 0.70-0.99). Overall, vaccination timeliness varied by antigen, with a slight decline over time for later-schedule vaccines such as MCV1. Residence, religion, and access to routine health services were key determinants of timely vaccination. Strengthening outreach, faith-based engagement, and reminder systems in informal settlements like Korogocho could enhance vaccine timeliness, particularly for vaccines administered later in infancy.

Identifiers

PMID41671251
PMCPMC12893561

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.